Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

X chromosomal abnormalities in basal-like human breast cancer.

Richardson AL, Wang ZC, De Nicolo A, Lu X, Brown M, Miron A, Liao X, Iglehart JD, Livingston DM, Ganesan S.

Cancer Cell. 2006 Feb;9(2):121-32.

2.

X inactive-specific transcript RNA coating and genetic instability of the X chromosome in BRCA1 breast tumors.

Vincent-Salomon A, Ganem-Elbaz C, Manié E, Raynal V, Sastre-Garau X, Stoppa-Lyonnet D, Stern MH, Heard E.

Cancer Res. 2007 Jun 1;67(11):5134-40.

3.

Abnormalities of the inactive X chromosome are a common feature of BRCA1 mutant and sporadic basal-like breast cancer.

Ganesan S, Richardson AL, Wang ZC, Iglehart JD, Miron A, Feunteun J, Silver D, Livingston DM.

Cold Spring Harb Symp Quant Biol. 2005;70:93-7.

PMID:
16869742
4.

Loss of the inactive X chromosome and replication of the active X in BRCA1-defective and wild-type breast cancer cells.

Sirchia SM, Ramoscelli L, Grati FR, Barbera F, Coradini D, Rossella F, Porta G, Lesma E, Ruggeri A, Radice P, Simoni G, Miozzo M.

Cancer Res. 2005 Mar 15;65(6):2139-46.

5.

Genomic signature of BRCA1 deficiency in sporadic basal-like breast tumors.

Joosse SA, Brandwijk KI, Mulder L, Wesseling J, Hannemann J, Nederlof PM.

Genes Chromosomes Cancer. 2011 Feb;50(2):71-81. doi: 10.1002/gcc.20833.

PMID:
21104783
6.
7.

Escape from gene silencing in ICF syndrome: evidence for advanced replication time as a major determinant.

Hansen RS, Stöger R, Wijmenga C, Stanek AM, Canfield TK, Luo P, Matarazzo MR, D'Esposito M, Feil R, Gimelli G, Weemaes CM, Laird CD, Gartler SM.

Hum Mol Genet. 2000 Nov 1;9(18):2575-87.

8.

Human BRCA1-associated breast cancer: no increase in numerical chromosomal instability compared to sporadic tumors.

Focken T, Steinemann D, Skawran B, Hofmann W, Ahrens P, Arnold N, Kroll P, Kreipe H, Schlegelberger B, Gadzicki D.

Cytogenet Genome Res. 2011;135(2):84-92. doi: 10.1159/000332005. Epub 2011 Oct 24.

PMID:
22024613
9.

X-inactivation profile reveals extensive variability in X-linked gene expression in females.

Carrel L, Willard HF.

Nature. 2005 Mar 17;434(7031):400-4.

PMID:
15772666
10.

BRCA1 supports XIST RNA concentration on the inactive X chromosome.

Ganesan S, Silver DP, Greenberg RA, Avni D, Drapkin R, Miron A, Mok SC, Randrianarison V, Brodie S, Salstrom J, Rasmussen TP, Klimke A, Marrese C, Marahrens Y, Deng CX, Feunteun J, Livingston DM.

Cell. 2002 Nov 1;111(3):393-405.

11.

Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.

Lose F, Duffy DL, Kay GF, Kedda MA, Spurdle AB; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer; Australian Ovarian Cancer Study Management Group.

J Natl Cancer Inst. 2008 Nov 5;100(21):1519-29. doi: 10.1093/jnci/djn345. Epub 2008 Oct 28.

12.

Gene body-specific methylation on the active X chromosome.

Hellman A, Chess A.

Science. 2007 Feb 23;315(5815):1141-3.

13.

Association of BRCA1 with the inactive X chromosome and XIST RNA.

Ganesan S, Silver DP, Drapkin R, Greenberg R, Feunteun J, Livingston DM.

Philos Trans R Soc Lond B Biol Sci. 2004 Jan 29;359(1441):123-8.

14.

BCoR-L1 variation and breast cancer.

Lose F, Arnold J, Young DB, Brown CJ, Mann GJ, Pupo GM; Kathleen Cuningham Foundation Consortium for Research into Familial Breast Cancer, Khanna KK, Chenevix-Trench G, Spurdle AB.

Breast Cancer Res. 2007;9(4):R54. Erratum in: Breast Cancer Res. 2008;10(5):406.

15.

The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.

Karpinski P, Ramsey D, Grzebieniak Z, Sasiadek MM, Blin N.

Mol Cancer Res. 2008 Apr;6(4):585-91. doi: 10.1158/1541-7786.MCR-07-2158.

16.

The X chromosome is organized into a gene-rich outer rim and an internal core containing silenced nongenic sequences.

Clemson CM, Hall LL, Byron M, McNeil J, Lawrence JB.

Proc Natl Acad Sci U S A. 2006 May 16;103(20):7688-93. Epub 2006 May 8.

17.

Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes.

Melchor L, Honrado E, García MJ, Alvarez S, Palacios J, Osorio A, Nathanson KL, Benítez J.

Oncogene. 2008 May 15;27(22):3165-75. Epub 2007 Dec 10.

PMID:
18071313
18.

Misbehaviour of XIST RNA in breast cancer cells.

Sirchia SM, Tabano S, Monti L, Recalcati MP, Gariboldi M, Grati FR, Porta G, Finelli P, Radice P, Miozzo M.

PLoS One. 2009;4(5):e5559. doi: 10.1371/journal.pone.0005559. Epub 2009 May 15.

19.

X-inactivation in female human embryonic stem cells is in a nonrandom pattern and prone to epigenetic alterations.

Shen Y, Matsuno Y, Fouse SD, Rao N, Root S, Xu R, Pellegrini M, Riggs AD, Fan G.

Proc Natl Acad Sci U S A. 2008 Mar 25;105(12):4709-14. doi: 10.1073/pnas.0712018105. Epub 2008 Mar 13.

20.

Characterization of loss-of-inactive X in Klinefelter syndrome and female-derived cancer cells.

Kawakami T, Zhang C, Taniguchi T, Kim CJ, Okada Y, Sugihara H, Hattori T, Reeve AE, Ogawa O, Okamoto K.

Oncogene. 2004 Aug 12;23(36):6163-9.

PMID:
15195139
Items per page

Supplemental Content

Write to the Help Desk